Corvus Pharmaceuticals Inc (CRVS.OQ)
CRVS.OQ on NASDAQ Stock Exchange Global Market
10.66USD
20 Apr 2018
10.66USD
20 Apr 2018
Change (% chg)
$0.01 (+0.09%)
$0.01 (+0.09%)
Prev Close
$10.65
$10.65
Open
$10.65
$10.65
Day's High
$11.06
$11.06
Day's Low
$10.55
$10.55
Volume
15,477
15,477
Avg. Vol
40,708
40,708
52-wk High
$17.54
$17.54
52-wk Low
$7.45
$7.45
Consensus Recommendations
| Consensus Recommendation | Next Earnings (approx.) | Company Fiscal Year End Month |
Last Updated |
|---|---|---|---|
| Outperform | -0.79 | December | 21 Apr 2018 |
Analyst Recommendations and Revisions
| 1-5 Linear Scale | Current | 1 Month Ago |
2 Month Ago |
3 Month Ago |
|---|---|---|---|---|
| (1) BUY | 3 | 3 | 3 | 3 |
| (2) OUTPERFORM | 2 | 2 | 2 | 2 |
| (3) HOLD | 1 | 1 | 1 | 1 |
| (4) UNDERPERFORM | 0 | 0 | 0 | 0 |
| (5) SELL | 0 | 0 | 0 | 0 |
| No Opinion | 0 | 0 | 0 | 0 |
| Mean Rating | 1.67 | 1.67 | 1.67 | 1.67 |
Consensus Estimates Analysis
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| # of Estimates | Mean | High | Low | 1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Sep-18 | 2 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 3 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 4 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | 5 | -0.79 | -0.69 | -0.86 | -- |
| Quarter Ending Sep-18 | 5 | -0.76 | -0.60 | -0.86 | -- |
| Year Ending Dec-18 | 4 | -3.14 | -2.82 | -3.42 | -3.89 |
| Year Ending Dec-19 | 6 | -3.29 | -2.19 | -4.30 | -3.95 |
Historical Surprises
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Estimates vs Actual | Estimate | Actual | Difference | Surprise % |
|---|---|---|---|---|
| SALES (in millions) | ||||
| Quarter Ending Dec-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Jun-17 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Dec-16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Quarter Ending Sep-16 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | ||||
| Quarter Ending Dec-17 | -0.77 | -0.58 | 0.19 | -24.56 |
| Quarter Ending Sep-17 | -0.81 | -0.62 | 0.19 | -23.74 |
| Quarter Ending Jun-17 | -0.74 | -0.73 | 0.01 | -1.08 |
| Quarter Ending Mar-17 | -0.77 | -0.79 | 0.02 | -2.56 |
| Quarter Ending Dec-16 | -0.57 | -0.55 | 0.02 | -2.79 |
Consensus Estimates Trend
Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
| Current | 1 Week Ago |
1 Month Ago |
2 Month Ago |
1 Year Ago |
|
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Jun-18 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Quarter Ending Sep-18 | 0.00 | 0.00 | 0.00 | 0.00 | -- |
| Year Ending Dec-18 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Year Ending Dec-19 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Earnings (per share) | |||||
| Quarter Ending Jun-18 | -0.79 | -0.79 | -0.79 | -0.86 | -- |
| Quarter Ending Sep-18 | -0.76 | -0.76 | -0.76 | -0.81 | -- |
| Year Ending Dec-18 | -3.14 | -3.14 | -3.14 | -3.29 | -3.89 |
| Year Ending Dec-19 | -3.29 | -3.29 | -3.29 | -3.40 | -3.95 |
Estimates Revisions Summary
| Last Week | Last 4 Weeks | |||
|---|---|---|---|---|
| Number Of Revisions: | Up | Down | Up | Down |
| Revenue | ||||
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
| Earnings | ||||
| Quarter Ending Jun-18 | 0 | 0 | 0 | 0 |
| Quarter Ending Sep-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-18 | 0 | 0 | 0 | 0 |
| Year Ending Dec-19 | 0 | 0 | 0 | 0 |
Earnings vs. 
Estimates- BRIEF-Adams Street Partners Reports 15.5 Pct Stake In Corvus Pharma
- BRIEF-BVF Partners Reports 6.7 Pct Passive Stake In Corvus Pharmaceuticals
- BRIEF-Corvus Pharmaceuticals Announces Closing Of Public Offering Of Common Stock
- BRIEF-Corvus Pharma Announces Pricing Of Public Offering Of Common Stock
- BRIEF-Corvus Pharma Announces Proposed Public Offering Of Common Stock